Hepatitis C Treatment at the University of Chicago (videos)



Dr. Donald Jensen and Dr. Andrew Aronsohn of the University of Chicago Center for Liver Diseases answer basic questions about hepatitis C, such as how it is contracted, diagnosed, and treated.



Dr. Donald Jensen and Dr. Andrew Aronsohn of the University of Chicago Center for Liver Diseases talk about hepatitis C care at the Medical Center.



Dr. Donald Jensen and Dr. Andrew Aronsohn of the University of Chicago Center for Liver Diseases discuss boceprevir and telaprevir, two recently approved therapies for hepatitis C.



Dr. Donald Jensen and Dr. Andrew Aronsohn of the University of Chicago Center for Liver Diseases discuss how clinics must decide which patients are the first to receive the two recently approved therapies for hepatitis C.

No comments:

Post a Comment